{"name":"PanTher Therapeutics","slug":"panther-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-19","type":"pipeline","source":"The Manila Times","summary":"Vesicor Therapeutics Appoints Michael Tolentino, M.D., as Chief Executive Officer - The Manila Times","headline":"Vesicor Therapeutics Appoints Michael Tolentino, M.D., as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQY1hsd1VZem1FSU9WQzVFanhwSThOdnJZUzNBNEU1R2x2SUxiT3huQmoyUTlZd1Z3QTZTMzN5VjluYlNnNEJBU0drWG5OUkJwb1dCMGdneXE0VDJJY3BTdzl2S3JMQi0tT3pUc1VRTGpYTXJKMUVEUGNSX0ctWDA1NXlnNDBybF9JSWlGSFVRNmZDVDVlS0RjdmZERllpQnItb3IxOEVaYw?oc=5","date":"2025-10-10","type":"pipeline","source":"Fierce Biotech","summary":"Amid the dip, biotech execs share silver linings in a tumultuous environment - Fierce Biotech","headline":"Amid the dip, biotech execs share silver linings in a tumultuous environment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOamZMWTByZ19pNHA3RjlkOGo5RkY3U0g1UnktcG01SGNfWTN6WTM4VGdRRXhJand2SE9EdEowZTAtM2o5cjd4T3NBTGt6Q3NpMmlQbEFvN1ROdmlHZnhpR3RGS18yYmJEUXM0bC11NkFVd20wRzRZSF9Fem5hQkU0VWdYVUFLODJSemVEUVVxTkZlT01ZVVNwWVpQSi1pNHpVc1d6dDUwdHpud2V2V01TYlJwV01vVU80YkhHS19QTWVkWDJLdFc4?oc=5","date":"2025-09-11","type":"trial","source":"BioSpace","summary":"PanTher Completes First Cohort in Pancreatic Cancer Phase 1b Trial Ahead of Expectations - BioSpace","headline":"PanTher Completes First Cohort in Pancreatic Cancer Phase 1b Trial Ahead of Expectations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE44VG4yUmFsc3oyU0FTLUU0aHJDVVpXdE1EMXlSdEVmQlJhS25vMENfTFRiZkpuc0FyZ09oQWlsU1lGTVBYaHFaV0hiZjFLZkx1VVY4VFBxLW1Ldw?oc=5","date":"2025-09-08","type":"pipeline","source":"University of Pittsburgh","summary":"The Dawn of BioForge - University of Pittsburgh","headline":"The Dawn of BioForge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNbXVZdmFfaVNqbm1iOFFqbE9SNWtkZ0hGaXktZDFrWkM2MElCdGlmNXhDcENDM2ZZX2dpNEw2RjR0WFlSYllYODRxNGFNLWdiX3VDcEd4bmdyWks4UHY0RDdLM3U3Q00zb1A1eWtEOHJwT2FaYlpYTE9JVG12cUZRVVoyRjE3aktTVWFfdkd5SExCWl9nbmllRkQ5XzVqZ0F2Z0Z6cWxn?oc=5","date":"2025-07-07","type":"trial","source":"Clinical Trials Arena","summary":"PanTher Therapeutics launches second trial for chemotherapy patch - Clinical Trials Arena","headline":"PanTher Therapeutics launches second trial for chemotherapy patch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxPbkVzMkE2U2NWem91Qk1xMFdZeG56a2hqcF92emhIZWVyZkpPN0RmZ0kySnBBX1pJclQ5TkZCdVY0V0tnMmVzYnl0cFpRQUg2YlFhQ3NDc2QxRzdTSlBRM1RiLThoM1VyMkcwMmhOcHNnZWo2SW1OcnhCOHNsN28zcUpJejJCVWptY3Robmt2NFpDYmlRU1E3LVJVXzRxcXVhSDJGWVQwLVczaTdUSlAxZEJfd3BIeW53aWVrU1B5NThQaHZhLWxCZzU2dmdfZVhESHJxc0I3NTdoeWZ0ZDA5aTRITjdUaUEyNW5FRkN6aW92NVlUTUE3RERSWHlpTk9YLWNocFl1MA?oc=5","date":"2025-07-07","type":"trial","source":"businesswire.com","summary":"PanTher Initiates Phase 1b Clinical Trial of Absorbable, Long-Lasting, High-Dose Chemotherapy Patch for Pancreatic Cancer - businesswire.com","headline":"PanTher Initiates Phase 1b Clinical Trial of Absorbable, Long-Lasting, High-Dose Chemotherapy Patch for Pancreatic Cance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE1ZXzRpVndROXRpOGg3YS0yTWVjdm9CZ3BuejktLWJtcnhvc1NoSEJBSGpEcGFhMndOalZrQk01bXlJTVhLc2M1b0gySGVDbW1uMzdVcDhkRWhidE1IZ2dzQzlIZG5QdEVMcGJvQg?oc=5","date":"2025-04-01","type":"pipeline","source":"antonhealth.com","summary":"Recent Limited Distribution Updates - antonhealth.com","headline":"Recent Limited Distribution Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxOdUhDdlVlYzdxWHRoQkp2Vmp1Wk1taExEWEZoU013T3hQQ3RjWkVsMjVjLW1vMXVHMUZKWnF0TFRRMzctTl9lQkdTMVp1UTFGaVZDcEMwYmRlSFBVWUNBd3JBaXluWTM5bFpFUFdyei1nYlh1T1Y3Zm8xVkFKanFYMXZnUTFtV2RiR0pXTXlXV3NpU3JlZ3RBYXF6aHBoSkFIOXZpLXlmMUIyVm9TbHdQdjQzN0g3bzN6OXM0NWdhVDk4ZnNmc0I0T3pjaklyaExjNEhLYWtBVldORDZRV2M2Y1NmOHJCcXQwUjI4cjdRUjNkNkFJZWZJVTBXQTNqdk8wT083LVBUaml1XzZWa3R2RXdSb2d1Y2Q1VV82VTdDX1ZkalVk?oc=5","date":"2024-08-13","type":"regulatory","source":"businesswire.com","summary":"PanTher Therapeutics Receives FDA Clearance of IND Application for Phase 1b Study of PTM-101 for the Localized Treatment of Pancreatic Cancer - businesswire.com","headline":"PanTher Therapeutics Receives FDA Clearance of IND Application for Phase 1b Study of PTM-101 for the Localized Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOYjhGQ1I3azN6TzdrZnB5czJFRFJwd3ZNSUItNTZKaG5Gb1hFX3JKRTNGeEhkbTBfaDhQa2xJNXFJbThWaUtiNEFFRWhKSTFnTXJhVjZPSk9QOEZXZ2ZlM0Q2ejBCWmZBSmJKb0ZjS2owVWJUY3pJLTgxcnczWEg3RWUwSEpkZlZpelNUNUIxSnAzcnlYM19iVHpHaFc2aDBIb19rVHVn?oc=5","date":"2023-05-31","type":"pipeline","source":"Duke Health","summary":"Black Men with Metastatic Prostate Cancer May Benefit From Drug Combination - Duke Health","headline":"Black Men with Metastatic Prostate Cancer May Benefit From Drug Combination","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxQeG9XRkY1WE9ncURNRmpJSFdaNVpfVEFXenBLWE5XeWdvZWM2Njh5VlZiNlVMMGRUMkpHMXNHaktZajV0WVNwdG9oTHBRaEk0RWRwWmEwXzJabVBKR1BUYUNOTy02NHU3N2FwLWdPbVlreGpBWVpCOGZreUJlRWw0SmotSXoxMHRtdF82cDNiQnBkMkQtZDRtOG1iOTRaZjFoQ3ZrbF85T0o2VGctcGhDYWROV1pLZzQwYTdlY2paeEdYR3pnZUdtSWtzWFVsSThDaXV2aW90cTJUMThDTGEtaWxTRFJLTEs3WlV0UVIxbDFMa0FJanNUUnVB?oc=5","date":"2022-08-22","type":"pipeline","source":"businesswire.com","summary":"PanTher Therapeutics Awarded $14.2M from CPRIT to Advance Targeted, Localized and Sustained Cancer Treatment - businesswire.com","headline":"PanTher Therapeutics Awarded $14.2M from CPRIT to Advance Targeted, Localized and Sustained Cancer Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBxc0lsUl9Dc0FSS2JpdTI0LVAwdHhqVWUzcTlmYXprMTh6U0RPb2xDMFRaY1F0dTk4RVRtNUQ2RmlDMTJ1Z1JIUUpIT185UGtRbHhhQjlkd2hxWWdjZkhZ?oc=5","date":"2022-03-03","type":"pipeline","source":"Nature","summary":"Attacking cancer at the source to improve clinical outcomes while minimizing side effects - Nature","headline":"Attacking cancer at the source to improve clinical outcomes while minimizing side effects","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOZXhLZUVPN2V5amtTX2k3bng3UlZpNXRZNU5yLURjVk82SXc4b0VRYnFjdHNDVE56amNrYTZ4dUt3ZDdUZ0xaSHRIMUR1MllyU2xmNjBGODR2VFU3dlllY1kwY0ZPNHNLMjRFaThWWWExUGhEWk9HT2xlTGZTYTUyMVNFQ25fY0E?oc=5","date":"2016-08-17","type":"pipeline","source":"inc.com","summary":"How a College Professor Built a $42 Million Pharmacy for Rare Disease Drugs - inc.com","headline":"How a College Professor Built a $42 Million Pharmacy for Rare Disease Drugs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}